Staphylococcal Toxin-Mediated Scalded Skin and Toxic Shock Syndromes


The toxin-mediated staphylococcal syndromes of staphylococcal scalded skin syndrome (SSSS) and toxic shock syndrome (TS) constitute important dermatologic entities capable of producing significant morbidity and mortality. Distinctive clinical and pathologic attributes usually permit their early recognition allowing for prompt institution of potentially life-saving therapy.


Necrotizing Fasciitis Toxic Epidermal Necrolysis Toxic Shock Syndrome Scarlet Fever Streptococcal Toxic Shock Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.



  1. 1.
    Ritter von Rittershain G. Die exfoliative Dermatitis jungerer Sauglinge. Zentralzeitung fur Kinderheilkunde 1878; 2: 3.Google Scholar
  2. 2.
    Melish M. Staphylococci, streptococci and the skin: Review of impetigo and the staphylococcal scalded skin syndrome. Semin Dermatol 1992; 1: 101.Google Scholar
  3. 3.
    Amagi M, Matsuyoshi N, Wang Z, et al. Toxin in bullous impetigo and staphylococcus scalded skin syndrome targets desmoglein 1. Nat Med 2000; 6: 1275.CrossRefGoogle Scholar
  4. 4.
    Hardwick N, Richard M, Mathieu-Serra A. Staphylococcal scalded skin syndrome in a homosexual adult. J Am Acad Dermatol 1986; 15: 385.Google Scholar
  5. 5.
    Cribier B, Piemont Y, Grosshans E. Staphylococcal scalded skin syndrome in adults: A clinical review illustrated with a new case. J Am Acad Dermatol 1994; 30: 319.PubMedCrossRefGoogle Scholar
  6. 6.
    Lyell A. The staphylococcal scalded skin syndrome in historical perspective: Emergence of dermopathic strains of staphylococcus aureus and discovery of the epidermolytic toxin. J Am Acad Dermatol 1983; 9: 285.PubMedGoogle Scholar
  7. 7.
    Richard M, Mathieu-Serra A. Staphylococcal scalded skin syndrome in a homosexual man. J Am Acad Dermatol 1986; 15: 385.PubMedGoogle Scholar
  8. 8.
    Institute of Medicine. National Academy of Science: Conference on the toxic shock syndrome. Ann Intern Med 1982; 96: 835.Google Scholar
  9. 9.
    Tofte R, Williams D. Toxic shock syndrome: Clinical and laboratory features in 15 patients. Ann Intern Med 1981; 94: 149.PubMedGoogle Scholar
  10. 10.
    Huntley A, Tanabe J. Toxic shock syndrome as a complication of dermatologic surgery. J Am Acad Dermatol 1987; 16: 227.PubMedCrossRefGoogle Scholar
  11. 11.
    Manders S. Toxin-mediated streptococcal and staphylococcal disease. J Am Acad Dermatol 1998; 39: 383.PubMedCrossRefGoogle Scholar
  12. 12.
    Elias P, Fritsch P, Epstein E. Staphylococcal scalded skin syndrome: Clinical features, pathogenesis, and recent microbiological and biochemical developments. Arch Dermatol 1977; 113: 207.PubMedCrossRefGoogle Scholar
  13. 13.
    Cone L, Woodard D, Byrd R, Schulz K, Kopp S, Schlievert P. A recalcitrant, erythematous desquamating disorder associated with toxin-producing staphylococci in patients with HIV disease. J Infect Dis 1992; 165: 638.PubMedGoogle Scholar
  14. 14.
    Hurwitz R, Ackerman A. Cutaneous pathology of the toxic shock syndrome. Am J Dermatopathol 7: 563.Google Scholar
  15. 15.
    Schlievert P. Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses. J Allergy Clin Immunol 2001; 108: S107.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Personalised recommendations